... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Valve diseases Biomarkers Prevention cardiology Cardiovascular...

...Sufeng Zhou; Anchen Zhang; Hua Liao; Zhebo Liu; Feiyan Yang Background: The coronavirus disease 2019 (COVID-19) involves all organs of the body, of which the interaction with cardiovascular diseases is the most important. Summary: Numerous studies have reported that COVID-19 patients complicated...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Cardiovascular diseases Lipids Risk factors Statins Cardiovascular disease (CVD) remains the most common cause...

... was excellent, with most side effects being transitory or reversible. Thus, based on the lipid hypothesis of atherosclerosis, therapy with fenofibrate can potentially lead to significant reductions in cardiovascular disease in type IIa and type IIb hyperlipoproteinemia. 12 11 2008 Fenofibrate, US...

...Silas R.A. Dodu Developing countries are subject to the same risks that have contributed to the high incidence of cardiovascular diseases in the already developed countries. Improvements in life expectancy at birth lead to predictable shifts in the cause-of-death structure over time. The stage...

... been observed in females aged 35-74. Looking at the whole group of cardiovascular diseases it appears that a continuous and clear decline in stroke mortality (-14.6% in males and -22.0% in females aged 35-74) explains almost completely the overall decrease of cardiovascular mortality observed during...

...Kimmo Aho; Jukka T. Salonen; Pekka Puska A randomly sampled population aged from 25 to 59 years and examined in 1972 was monitored for 5 years. During that period, 126 deaths from cardiovascular causes occurred among subjects with no recent history of major cardiovascular diseases. A control...